The application of a novel 5-in-1 multiplex reverse transcriptase–polymerase chain reaction assay for rapid detection of SARS-CoV-2 and differentiation between variants of concern
Hsing‐Yi Chung(Tri-Service General Hospital), Hung‐Sheng Shang(National Defense Medical Center), Shih-Yi Li(Tri-Service General Hospital), Kuo‐Sheng Hung(Tri-Service General Hospital), Cherng‐Lih Perng(Tri-Service General Hospital), Shenghui Tang(United States Food and Drug Administration), Kuo‐Ming Yeh(Tri-Service General Hospital), Chi‐Sheng Chen(National Defense Medical Center), Chien‐Wen Chen(Institute of Cellular and Organismic Biology, Academia Sinica), Chih-Kai Chang(University of British Columbia), Ya‐Sung Yang(Tri-Service General Hospital), Feng‐Yee Chang(Tri-Service General Hospital), Jung‐Chung Lin(Tri-Service General Hospital), Shan‐Shan Hsieh(Tri-Service General Hospital)
Cited by 2
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human Organs
|Cell stem cell|2008|4k
α-Synuclein impairs macroautophagy: implications for Parkinson’s disease
|The Journal of Cell Biology|2010|833